| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 3.24e-05 | 4 | 47 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.41e-04 | 43 | 47 | 3 | GO:0030280 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 6.37e-04 | 16 | 47 | 2 | GO:0005041 | |
| GeneOntologyCellularComponent | Golgi lumen | 6.19e-09 | 109 | 49 | 7 | GO:0005796 | |
| HumanPheno | Steatocystoma multiplex | 6.27e-05 | 4 | 17 | 2 | HP:0012035 | |
| HumanPheno | Eruptive vellus hair cyst | 6.27e-05 | 4 | 17 | 2 | HP:0025248 | |
| HumanPheno | Blistering by anatomical location | 7.66e-05 | 26 | 17 | 3 | HP:0033800 | |
| HumanPheno | White lesion of the oral mucosa | 9.61e-05 | 28 | 17 | 3 | HP:0025125 | |
| HumanPheno | Oral leukoplakia | 9.61e-05 | 28 | 17 | 3 | HP:0002745 | |
| HumanPheno | Linear arrays of macular hyperkeratoses in flexural areas | 1.04e-04 | 5 | 17 | 2 | HP:0007490 | |
| HumanPheno | Hyperplastic callus formation | 1.04e-04 | 5 | 17 | 2 | HP:0030268 | |
| HumanPheno | Onychogryposis | 1.07e-04 | 29 | 17 | 3 | HP:0001805 | |
| HumanPheno | Onychogryposis of toenails | 2.18e-04 | 7 | 17 | 2 | HP:0008401 | |
| HumanPheno | Onychogryposis | 2.18e-04 | 7 | 17 | 2 | HP:0001819 | |
| HumanPheno | Onychogryposis of fingernail | 3.72e-04 | 9 | 17 | 2 | HP:0040036 | |
| HumanPheno | Epidermoid cyst | 4.02e-04 | 45 | 17 | 3 | HP:0200040 | |
| HumanPheno | Palmoplantar keratoderma | 4.52e-04 | 114 | 17 | 4 | HP:0000982 | |
| MousePheno | abnormal tongue epithelium morphology | 4.40e-05 | 27 | 36 | 3 | MP:0000764 | |
| MousePheno | decreased keratinocyte adhesion | 9.61e-05 | 6 | 36 | 2 | MP:0030578 | |
| MousePheno | abnormal keratinocyte adhesion | 1.34e-04 | 7 | 36 | 2 | MP:0030576 | |
| MousePheno | abnormal filiform papillae morphology | 1.34e-04 | 7 | 36 | 2 | MP:0000763 | |
| MousePheno | heart inflammation | 1.35e-04 | 39 | 36 | 3 | MP:0001853 | |
| MousePheno | cardiomyopathy | 1.70e-04 | 109 | 36 | 4 | MP:0005330 | |
| MousePheno | decreased circulating unsaturated transferrin level | 1.79e-04 | 8 | 36 | 2 | MP:0011897 | |
| MousePheno | impaired macrophage phagocytosis | 2.83e-04 | 50 | 36 | 3 | MP:0001798 | |
| MousePheno | decreased circulating transferrin level | 2.86e-04 | 10 | 36 | 2 | MP:0011894 | |
| MousePheno | decreased circulating interleukin-10 level | 2.86e-04 | 10 | 36 | 2 | MP:0008594 | |
| MousePheno | abnormal keratinocyte morphology | 3.55e-04 | 54 | 36 | 3 | MP:0002655 | |
| Domain | SEA | 3.28e-07 | 23 | 48 | 4 | PS50024 | |
| Domain | SEA_dom | 3.28e-07 | 23 | 48 | 4 | IPR000082 | |
| Domain | EGF_1 | 3.72e-06 | 255 | 48 | 7 | PS00022 | |
| Domain | EGF-like_CS | 4.34e-06 | 261 | 48 | 7 | IPR013032 | |
| Domain | EGF_2 | 4.79e-06 | 265 | 48 | 7 | PS01186 | |
| Domain | SEA | 5.68e-06 | 14 | 48 | 3 | SM00200 | |
| Domain | ZF_CCHC_HIVEP | 6.47e-06 | 2 | 48 | 2 | PS51811 | |
| Domain | VWD | 8.71e-06 | 16 | 48 | 3 | SM00216 | |
| Domain | VWF_type-D | 8.71e-06 | 16 | 48 | 3 | IPR001846 | |
| Domain | VWFD | 8.71e-06 | 16 | 48 | 3 | PS51233 | |
| Domain | VWD | 8.71e-06 | 16 | 48 | 3 | PF00094 | |
| Domain | SEA | 2.37e-05 | 22 | 48 | 3 | PF01390 | |
| Domain | Keratin_2_head | 3.10e-05 | 24 | 48 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 3.10e-05 | 24 | 48 | 3 | PF16208 | |
| Domain | Keratin_II | 3.97e-05 | 26 | 48 | 3 | IPR003054 | |
| Domain | EGF_3 | 3.33e-04 | 235 | 48 | 5 | PS50026 | |
| Domain | EGF | 3.33e-04 | 235 | 48 | 5 | SM00181 | |
| Domain | TIL | 4.20e-04 | 12 | 48 | 2 | PF01826 | |
| Domain | C8 | 4.20e-04 | 12 | 48 | 2 | PF08742 | |
| Domain | EGF-like_dom | 4.34e-04 | 249 | 48 | 5 | IPR000742 | |
| Domain | Unchr_dom_Cys-rich | 4.95e-04 | 13 | 48 | 2 | IPR014853 | |
| Domain | C8 | 4.95e-04 | 13 | 48 | 2 | SM00832 | |
| Domain | Intermediate_filament_CS | 5.68e-04 | 63 | 48 | 3 | IPR018039 | |
| Domain | TIL_dom | 5.77e-04 | 14 | 48 | 2 | IPR002919 | |
| Domain | Ldl_recept_b | 5.77e-04 | 14 | 48 | 2 | PF00058 | |
| Domain | LDLRB | 5.77e-04 | 14 | 48 | 2 | PS51120 | |
| Domain | LY | 6.65e-04 | 15 | 48 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.65e-04 | 15 | 48 | 2 | IPR000033 | |
| Domain | Filament | 8.05e-04 | 71 | 48 | 3 | SM01391 | |
| Domain | IF | 8.39e-04 | 72 | 48 | 3 | PS00226 | |
| Domain | Filament | 8.73e-04 | 73 | 48 | 3 | PF00038 | |
| Domain | IF | 9.82e-04 | 76 | 48 | 3 | IPR001664 | |
| Domain | VWC_out | 1.08e-03 | 19 | 48 | 2 | SM00215 | |
| Domain | CT | 1.45e-03 | 22 | 48 | 2 | SM00041 | |
| Domain | Cys_knot_C | 1.87e-03 | 25 | 48 | 2 | IPR006207 | |
| Domain | CTCK_2 | 1.87e-03 | 25 | 48 | 2 | PS01225 | |
| Domain | Myosin_head_motor_dom | 4.29e-03 | 38 | 48 | 2 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.29e-03 | 38 | 48 | 2 | PS51456 | |
| Domain | Myosin_head | 4.29e-03 | 38 | 48 | 2 | PF00063 | |
| Domain | MYSc | 4.29e-03 | 38 | 48 | 2 | SM00242 | |
| Domain | - | 4.51e-03 | 39 | 48 | 2 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 4.74e-03 | 40 | 48 | 2 | IPR023415 | |
| Domain | VWF_dom | 5.22e-03 | 42 | 48 | 2 | IPR001007 | |
| Domain | Ldl_recept_a | 5.97e-03 | 45 | 48 | 2 | PF00057 | |
| Domain | - | 6.23e-03 | 46 | 48 | 2 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.23e-03 | 46 | 48 | 2 | IPR011042 | |
| Domain | - | 6.49e-03 | 47 | 48 | 2 | 3.30.420.10 | |
| Domain | LDLRA_1 | 6.77e-03 | 48 | 48 | 2 | PS01209 | |
| Domain | LDLRA_2 | 7.04e-03 | 49 | 48 | 2 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 7.04e-03 | 49 | 48 | 2 | IPR002172 | |
| Domain | LDLa | 7.04e-03 | 49 | 48 | 2 | SM00192 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.68e-12 | 16 | 37 | 6 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.59e-12 | 17 | 37 | 6 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.09e-11 | 23 | 37 | 6 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 4.73e-11 | 26 | 37 | 6 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.18e-08 | 62 | 37 | 6 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.08e-08 | 68 | 37 | 6 | M27303 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.33e-07 | 21 | 37 | 4 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.96e-07 | 111 | 37 | 6 | M27416 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.55e-06 | 140 | 37 | 6 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.76e-06 | 143 | 37 | 6 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.76e-05 | 60 | 37 | 4 | MM15636 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 4.29e-05 | 250 | 37 | 6 | M27554 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.84e-04 | 109 | 37 | 4 | MM15164 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 3.50e-04 | 129 | 37 | 4 | M27649 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 4.87e-04 | 1128 | 37 | 10 | M1036 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS | 7.86e-04 | 16 | 37 | 2 | M27403 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 1.36e-03 | 21 | 37 | 2 | M39593 | |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 1.50e-03 | 22 | 37 | 2 | M9703 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.52e-03 | 87 | 37 | 3 | MM15351 | |
| Pathway | REACTOME_SIGNALING_BY_ALK_IN_CANCER | 1.84e-03 | 93 | 37 | 3 | M42521 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.19e-13 | 18 | 50 | 6 | 18834073 | |
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 29357356 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 7543104 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 20301457 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 19110483 | ||
| Pubmed | 1.38e-07 | 417 | 50 | 8 | 19199708 | ||
| Pubmed | Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA. | 6.09e-07 | 12 | 50 | 3 | 14610062 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 11118885 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 12958310 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 10550543 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 10550545 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 9790766 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 2.03e-06 | 2 | 50 | 2 | 10973822 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23662636 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 38411280 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 9334251 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 11489919 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 10866680 | ||
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 2.03e-06 | 2 | 50 | 2 | 2393399 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 10953016 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 6207530 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 11289722 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23544943 | ||
| Pubmed | Cytokeratins mediate epithelial innate defense through their antimicrobial properties. | 2.03e-06 | 2 | 50 | 2 | 23006328 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 14690056 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 28649694 | ||
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 2.03e-06 | 2 | 50 | 2 | 10405327 | |
| Pubmed | AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. | 3.65e-06 | 21 | 50 | 3 | 18824566 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 23446997 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 23053434 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 17170733 | ||
| Pubmed | Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression. | 6.07e-06 | 3 | 50 | 2 | 23305535 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 15601842 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 29587848 | ||
| Pubmed | A role for keratins in supporting mitochondrial organization and function in skin keratinocytes. | 6.07e-06 | 3 | 50 | 2 | 32213122 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 27230679 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 30236127 | ||
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 6.07e-06 | 3 | 50 | 2 | 18163520 | |
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 6.07e-06 | 3 | 50 | 2 | 17592322 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 26770020 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 10512748 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 26821944 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 17851587 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 14573483 | ||
| Pubmed | Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. | 6.07e-06 | 3 | 50 | 2 | 14568992 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 35879412 | ||
| Pubmed | Identification of a cloned sequence activated during multi-stage carcinogenesis in mouse skin. | 6.07e-06 | 3 | 50 | 2 | 1713533 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 27483328 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 24204560 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 24939955 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 30389720 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 17471237 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 14984930 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 22264670 | ||
| Pubmed | Mouse models in preclinical studies for pachyonychia congenita. | 1.21e-05 | 4 | 50 | 2 | 16250208 | |
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 1.21e-05 | 4 | 50 | 2 | 29869461 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 21596555 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 9054461 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 23807779 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 15863839 | ||
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 1.21e-05 | 4 | 50 | 2 | 39024979 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 12676567 | ||
| Pubmed | 1.22e-05 | 31 | 50 | 3 | 20930145 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.36e-05 | 774 | 50 | 8 | 15302935 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 2.02e-05 | 5 | 50 | 2 | 11062147 | |
| Pubmed | Airway hillocks are injury-resistant reservoirs of unique plastic stem cells. | 2.02e-05 | 5 | 50 | 2 | 38693267 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 30938030 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 24840470 | ||
| Pubmed | Role for keratins 6 and 17 during wound closure in embryonic mouse skin. | 2.02e-05 | 5 | 50 | 2 | 12557214 | |
| Pubmed | Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12. | 2.02e-05 | 5 | 50 | 2 | 1713141 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 23075894 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 31898934 | ||
| Pubmed | ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. | 2.02e-05 | 5 | 50 | 2 | 17084711 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 2.02e-05 | 5 | 50 | 2 | 16475027 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 16239341 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 25704602 | ||
| Pubmed | p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration. | 3.03e-05 | 6 | 50 | 2 | 25383540 | |
| Pubmed | ATM mediates pRB function to control DNMT1 protein stability and DNA methylation. | 3.03e-05 | 6 | 50 | 2 | 23754744 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 16790075 | ||
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | 3.15e-05 | 630 | 50 | 7 | 36949045 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 25104574 | ||
| Pubmed | Frizzled6 deficiency disrupts the differentiation process of nail development. | 4.23e-05 | 7 | 50 | 2 | 23439395 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 19720911 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 15371305 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 18485343 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 33294854 | ||
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 16093647 | ||
| Pubmed | Type II keratins precede type I keratins during early embryonic development. | 7.25e-05 | 9 | 50 | 2 | 16180309 | |
| Pubmed | Periderm Fate during Palatogenesis: TGF-β and Periderm Dedifferentiation. | 7.25e-05 | 9 | 50 | 2 | 36751050 | |
| Pubmed | RIP4 regulates epidermal differentiation and cutaneous inflammation. | 7.25e-05 | 9 | 50 | 2 | 19626033 | |
| Pubmed | 7.74e-05 | 57 | 50 | 3 | 31862882 | ||
| Pubmed | 8.84e-05 | 162 | 50 | 4 | 15174051 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 19906316 | ||
| Pubmed | Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1. | 9.05e-05 | 10 | 50 | 2 | 26075824 | |
| Pubmed | 1.04e-04 | 63 | 50 | 3 | 16831889 | ||
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 35593401 | ||
| Pubmed | 1.30e-04 | 179 | 50 | 4 | 19074885 | ||
| Pubmed | Assignment of the mouse ataxia-telangiectasia gene (Atm) to mouse chromosome 9. | 1.32e-04 | 12 | 50 | 2 | 8672141 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.66e-04 | 1105 | 50 | 8 | 35748872 | |
| Pubmed | 1.76e-04 | 75 | 50 | 3 | 31527668 | ||
| Interaction | PHTF1 interactions | 1.32e-05 | 20 | 47 | 3 | int:PHTF1 | |
| Interaction | YWHAZ interactions | PRKD2 KRT6B MYO3A ABI1 HIVEP1 SSH1 DSG2 ATM PIAS1 GLCCI1 MAST3 DNMT1 | 3.60e-05 | 1319 | 47 | 12 | int:YWHAZ |
| Interaction | KRT28 interactions | 4.62e-05 | 30 | 47 | 3 | int:KRT28 | |
| Interaction | KRT26 interactions | 7.38e-05 | 35 | 47 | 3 | int:KRT26 | |
| Interaction | KRT25 interactions | 7.38e-05 | 35 | 47 | 3 | int:KRT25 | |
| Interaction | KRT31 interactions | 8.00e-05 | 453 | 47 | 7 | int:KRT31 | |
| Cytoband | 7q22 | 9.98e-06 | 38 | 50 | 3 | 7q22 | |
| Cytoband | 12q13.13 | 5.54e-05 | 67 | 50 | 3 | 12q13.13 | |
| Cytoband | 19p13.2 | 1.16e-04 | 229 | 50 | 4 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 3.54e-04 | 307 | 50 | 4 | chr17q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.73e-03 | 797 | 50 | 5 | chr19p13 | |
| GeneFamily | CD molecules|Mucins | 1.69e-14 | 21 | 40 | 7 | 648 | |
| GeneFamily | Keratins, type II | 2.83e-05 | 27 | 40 | 3 | 609 | |
| GeneFamily | Low density lipoprotein receptors | 3.67e-04 | 13 | 40 | 2 | 634 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 5.47e-03 | 50 | 40 | 2 | 1293 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | HIVEP3 PRKD2 PHC3 IL16 ABI1 SSH1 KCMF1 RNF213 ATM TNRC6C GPATCH8 REV3L GLCCI1 MAST3 DNMT1 | 3.66e-08 | 1492 | 48 | 15 | M40023 |
| Coexpression | NABA_ECM_AFFILIATED | 6.67e-07 | 170 | 48 | 6 | M5880 | |
| Coexpression | GU_PDEF_TARGETS_DN | 8.62e-07 | 40 | 48 | 4 | M10480 | |
| Coexpression | GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN | 3.08e-05 | 198 | 48 | 5 | M9800 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN | 3.15e-05 | 199 | 48 | 5 | M5268 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_3_CELL | 5.77e-05 | 226 | 48 | 5 | M45709 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_DN | 6.30e-05 | 117 | 48 | 4 | M9403 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL | 7.46e-05 | 775 | 48 | 8 | M45713 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.30e-10 | 176 | 49 | 7 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.47e-09 | 188 | 49 | 7 | 07705bed928683470a52c8ccfa40ffb9a0971318 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.19e-09 | 199 | 49 | 7 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.19e-09 | 199 | 49 | 7 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.19e-09 | 199 | 49 | 7 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.74e-08 | 174 | 49 | 6 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 3.87e-08 | 175 | 49 | 6 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 3.87e-08 | 175 | 49 | 6 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.42e-08 | 179 | 49 | 6 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.57e-08 | 180 | 49 | 6 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.57e-08 | 180 | 49 | 6 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-08 | 192 | 49 | 6 | 612be3f861bd2f71a31c57f48c8b10930c3471ea | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-08 | 192 | 49 | 6 | f627a3f43e2340c8ba502211940171f25c7ff436 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 7.81e-08 | 197 | 49 | 6 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.04e-08 | 198 | 49 | 6 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-08 | 198 | 49 | 6 | de5987588b9fa9ee8c595ba06d7d844ead0e3c74 | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.04e-08 | 198 | 49 | 6 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.04e-08 | 198 | 49 | 6 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.29e-08 | 199 | 49 | 6 | 3c3133d0aa65338a576634def13e7f0f5c573a10 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.29e-08 | 199 | 49 | 6 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.29e-08 | 199 | 49 | 6 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.29e-08 | 199 | 49 | 6 | a706ad5cd5e0dc8d7e925a05e45b07d35963f294 | |
| ToppCell | Tracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.54e-08 | 200 | 49 | 6 | efd461c687155c84ef590352207e6fe4ba392a90 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.54e-08 | 200 | 49 | 6 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.97e-07 | 152 | 49 | 5 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.26e-07 | 161 | 49 | 5 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.54e-07 | 162 | 49 | 5 | 112fa4de685727f6c8bf6fc4afb82de0524070ad | |
| ToppCell | Club_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.08e-06 | 166 | 49 | 5 | a440aa338aa0c6cd0b5800dfa7e83f8ca16fce1a | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.32e-06 | 173 | 49 | 5 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.60e-06 | 180 | 49 | 5 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.74e-06 | 183 | 49 | 5 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.79e-06 | 184 | 49 | 5 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.79e-06 | 184 | 49 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-06 | 187 | 49 | 5 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.20e-06 | 192 | 49 | 5 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 2.20e-06 | 192 | 49 | 5 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.31e-06 | 194 | 49 | 5 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-06 | 194 | 49 | 5 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-06 | 195 | 49 | 5 | fc2a1d84b3d013e5cb9e7b9cdd740e4010897d20 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-06 | 195 | 49 | 5 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.43e-06 | 196 | 49 | 5 | 808c0a7d1889a8f3508ed9790c6dc7ec16bbc840 | |
| ToppCell | (01)_IL1RL1+-(1)_GFP|(01)_IL1RL1+ / shred by cell type by condition | 2.43e-06 | 196 | 49 | 5 | b598b1112242534e139318012b257ed3cb09da83 | |
| ToppCell | 15-Trachea|15 / Age, Tissue, Lineage and Cell class | 2.43e-06 | 196 | 49 | 5 | fd17403422cf95c24f6be1c2d78764bb352f7f2e | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 2.43e-06 | 196 | 49 | 5 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.43e-06 | 196 | 49 | 5 | faa39c567f24403e511b240c1d1a654ffadd8473 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.43e-06 | 196 | 49 | 5 | 60ea673ed887fe3890c5cf4ff4165384b76d7361 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.43e-06 | 196 | 49 | 5 | b246e482f012dd9782b49c2a953acedfa3c1139d | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-06 | 197 | 49 | 5 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | 3'-Broncho-tracheal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-06 | 197 | 49 | 5 | 5d33f8a6940431093e927b186fb9b630a89d8ec1 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-06 | 197 | 49 | 5 | e2c820c4e4a6cd01ceb020473286e3f5d4e3718e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-06 | 198 | 49 | 5 | 9718f4c013c347f1b3c785ae232dd2fb6c1fe298 | |
| ToppCell | 21-Trachea-Epithelial-Club-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 2.56e-06 | 198 | 49 | 5 | e735d82e5151c98b5724c543f8ad633c8ed824d2 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.56e-06 | 198 | 49 | 5 | 6e047de63ef59dcb47e4fc06b173b2a02fdcf4c9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-06 | 198 | 49 | 5 | 89ec1e760a193441092571475cc66a3b425f232e | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-06 | 198 | 49 | 5 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-06 | 198 | 49 | 5 | aa6e7218ee6230902854e66c444b544218b30c0e | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-06 | 198 | 49 | 5 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-06 | 198 | 49 | 5 | 22935a8afac54021f68b5f7a5accf51523e2f336 | |
| ToppCell | 5'-Adult|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-06 | 199 | 49 | 5 | 8b7b1fcea9a06522fdfab85d0dfd33010ae96d75 | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5B+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.62e-06 | 199 | 49 | 5 | afd0df242a93f176438309668a9487be1250d9ca | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.62e-06 | 199 | 49 | 5 | ec1e110671e7725f752163c7241dbbf638dec2b2 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.62e-06 | 199 | 49 | 5 | f5c3561744e2a0e7716657cb521acb1d8f054b41 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.69e-06 | 200 | 49 | 5 | c7668e26c6b8cfa6d174b0634e43c230425faba9 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | afac850d5a40de0d6f02857cf81a19443d90b1eb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.69e-06 | 200 | 49 | 5 | 621dd6438ef6e71811d3644b75209535b7c0f8f7 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.69e-06 | 200 | 49 | 5 | bce9bce9eb622bc6514708d49ca4a6604043c22a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Severe-Epithelial-Epithelial-|Severe / Condition, Lineage, Cell class and cell subclass | 2.69e-06 | 200 | 49 | 5 | 8669ce08f93eefb8ac970e30cdc4b1f908023c54 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.69e-06 | 200 | 49 | 5 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| ToppCell | Severe-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 2.69e-06 | 200 | 49 | 5 | 6ead9db88568bb829d564a6d8e85f71fd765bac0 | |
| ToppCell | Severe-Epithelial-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 2.69e-06 | 200 | 49 | 5 | 3bd1ce2793651c9badd69f011d2531183594e5f4 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | 0594ca7bc313b73e1dc800cf058f8f798b0284cb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 153 | 49 | 4 | 499670e716fc85ce76630fc813cec86f8419f2a1 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.74e-05 | 158 | 49 | 4 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-05 | 159 | 49 | 4 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | Club_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.95e-05 | 161 | 49 | 4 | bd08a23b415617f6e8748ed2668d578a860ecf91 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-05 | 163 | 49 | 4 | f6847f47a8856c0d4136c1af317432d45eccfde9 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-05 | 163 | 49 | 4 | a1fbefe53523a9879a4d4b493071059798b5f917 | |
| ToppCell | 5'-Airway_Nasal_SMG|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-05 | 163 | 49 | 4 | d8450bf9c6d2ec5dd1472952c9e65f82f995337a | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-05 | 163 | 49 | 4 | 454a5e87e2f9f66e38cc5aa1b433c47b54c9be42 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-05 | 163 | 49 | 4 | be6cc44df9a2b10dce1a353717c279c3558f8fec | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-05 | 163 | 49 | 4 | d9bd9d90cfa4e85d5ea51f8f3ee14a700571f508 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.17e-05 | 164 | 49 | 4 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Dcn|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.23e-05 | 56 | 49 | 3 | 821d5939c7c8d3ebbb2e0c64d0197f639f02278a | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Dcn-Excitatory_Neuron.Slc17a7.Dcn-Pou3f1_(Anterior_Subiculum,_proximal_to_CA1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.23e-05 | 56 | 49 | 3 | a762127a14327e8ab55a3e25ec26a84cc3210693 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 3.73e-05 | 171 | 49 | 4 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.82e-05 | 172 | 49 | 4 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.91e-05 | 173 | 49 | 4 | d8e965ff7e9b758876ec1521c1ccedd739e8d673 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.91e-05 | 173 | 49 | 4 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.91e-05 | 173 | 49 | 4 | c2d973356c40e0284fd3bd7733a164b141c66008 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-5|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.00e-05 | 174 | 49 | 4 | 73e1ad4007d94fca25ed7c6fbe5d205d4e1b8a3b | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.00e-05 | 174 | 49 | 4 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-SMG_basal_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.00e-05 | 174 | 49 | 4 | aceca0a22bb1e380835e792681cfc9b752fb5496 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.27e-05 | 177 | 49 | 4 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.27e-05 | 177 | 49 | 4 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.27e-05 | 177 | 49 | 4 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.27e-05 | 177 | 49 | 4 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.68e-04 | 50 | 33 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.68e-04 | 50 | 33 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.68e-04 | 50 | 33 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE | |
| Computational | Neighborhood of PRKCG | 9.24e-04 | 63 | 33 | 3 | GCM_PRKCG | |
| Drug | SC-791 | 1.98e-07 | 6 | 50 | 3 | CID010291510 | |
| Drug | 4-hydroxytestosterone | 7.78e-07 | 78 | 50 | 5 | CID000160615 | |
| Drug | plakin | 9.99e-07 | 82 | 50 | 5 | CID000018752 | |
| Drug | cellobiitol | 1.29e-06 | 37 | 50 | 4 | CID000003871 | |
| Drug | mucic acid | 1.42e-06 | 88 | 50 | 5 | CID000000607 | |
| Drug | sodium dodecyl sulfate | 1.68e-06 | 91 | 50 | 5 | CID000008778 | |
| Drug | mant-GTP | 4.40e-06 | 50 | 50 | 4 | CID000128647 | |
| Drug | clobestasol propionate | 6.63e-06 | 17 | 50 | 3 | CID000002791 | |
| Drug | dithranol | 7.94e-06 | 18 | 50 | 3 | CID000002202 | |
| Drug | Olux | 1.11e-05 | 20 | 50 | 3 | CID000032797 | |
| Drug | N1-acetylspermidine | 1.11e-05 | 20 | 50 | 3 | CID000000496 | |
| Drug | MK-6 | 1.95e-05 | 24 | 50 | 3 | CID005283547 | |
| Drug | Bhg-(2-1)fuc | 2.22e-05 | 25 | 50 | 3 | CID005287784 | |
| Drug | betamethasone valerate | 3.14e-05 | 28 | 50 | 3 | CID000016533 | |
| Drug | AC1L9LMC | 3.33e-05 | 83 | 50 | 4 | CID000448113 | |
| Drug | 2-Formyl-Protoporphryn Ix | 4.29e-05 | 31 | 50 | 3 | CID011963946 | |
| Drug | AGN 193109 | 4.29e-05 | 31 | 50 | 3 | CID000177238 | |
| Drug | 4,4'-thiodiphenol | 4.73e-05 | 32 | 50 | 3 | CID000017570 | |
| Drug | rioprostil | 4.73e-05 | 32 | 50 | 3 | CID005311413 | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 6.78e-05 | 195 | 50 | 5 | 4817_UP | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 6.95e-05 | 196 | 50 | 5 | 5230_UP | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 7.12e-05 | 197 | 50 | 5 | 5815_DN | |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A | 7.12e-05 | 197 | 50 | 5 | 4553_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; PC3; HG-U133A | 7.29e-05 | 198 | 50 | 5 | 1918_UP | |
| Drug | chrysarobin | 7.35e-05 | 37 | 50 | 3 | CID000068111 | |
| Drug | tsuwabukinonol | 7.35e-05 | 37 | 50 | 3 | CID006440419 | |
| Drug | Khellin [82-02-0]; Up 200; 15.4uM; PC3; HG-U133A | 7.65e-05 | 200 | 50 | 5 | 1922_UP | |
| Drug | CaLam | 8.61e-05 | 39 | 50 | 3 | CID004126474 | |
| Drug | teleocidin B | 1.54e-04 | 123 | 50 | 4 | CID000072425 | |
| Drug | Gastrin tetrapeptide | 1.82e-04 | 50 | 50 | 3 | CID000005415 | |
| Drug | guanidine hydrochloride | 1.85e-04 | 129 | 50 | 4 | CID000005742 | |
| Disease | cholangiocarcinoma (is_marker_for) | 8.04e-08 | 64 | 50 | 5 | DOID:4947 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 3.54e-06 | 61 | 50 | 4 | DOID:3587 (is_marker_for) | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 1.68e-05 | 4 | 50 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 1.68e-05 | 4 | 50 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia congenita syndrome | 1.68e-05 | 4 | 50 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 1.68e-05 | 4 | 50 | 2 | C1721007 | |
| Disease | Pachyonychia Congenita | 2.80e-05 | 5 | 50 | 2 | C0265334 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 2.80e-05 | 5 | 50 | 2 | DOID:3030 (is_marker_for) | |
| Disease | eosinophil count | HIVEP3 PRKD2 PHC3 HIVEP1 MCIDAS LPO ATM PIAS1 GLCCI1 MAST3 CMTM8 | 3.13e-05 | 1488 | 50 | 11 | EFO_0004842 |
| Disease | heart rate response to exercise | 5.39e-05 | 43 | 50 | 3 | EFO_0009184 | |
| Disease | triacylglycerol 58:6 measurement | 7.83e-05 | 8 | 50 | 2 | EFO_0010440 | |
| Disease | sphingomyelin measurement | 1.07e-04 | 278 | 50 | 5 | EFO_0010118 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.17e-04 | 148 | 50 | 4 | C0279702 | |
| Disease | otitis media (is_marker_for) | 1.26e-04 | 10 | 50 | 2 | DOID:10754 (is_marker_for) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.17e-04 | 13 | 50 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 3.29e-04 | 194 | 50 | 4 | EFO_0004265, EFO_0007908 | |
| Disease | pancreatic cancer (is_marker_for) | 6.79e-04 | 101 | 50 | 3 | DOID:1793 (is_marker_for) | |
| Disease | Early Pregnancy Loss | 8.47e-04 | 109 | 50 | 3 | C3830362 | |
| Disease | Miscarriage | 8.47e-04 | 109 | 50 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 8.47e-04 | 109 | 50 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 8.47e-04 | 109 | 50 | 3 | C0000822 | |
| Disease | esterified cholesterol measurement | 1.35e-03 | 128 | 50 | 3 | EFO_0008589 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTFHSLSLRSTSTRL | 66 | Q96KT6 | |
| HSMTRSSSTIRSRVT | 361 | Q8NEC5 | |
| RITRKSTRQTTITSH | 156 | P26358 | |
| ASSRHVESSSQRTET | 66 | A8MU93 | |
| VESSSQRTETTSRHV | 71 | A8MU93 | |
| QRTETTSRHVRASSL | 76 | A8MU93 | |
| RQISRHNSTTSSTSS | 316 | Q8IZP0 | |
| VRTSSTIRRTSSLDT | 161 | Q86VQ1 | |
| PRRASTVATSTHRTT | 651 | A6H8M9 | |
| AHTSTVLTTTATTTR | 3831 | Q9HC84 | |
| HTSTVLTTKATTTRA | 4361 | Q9HC84 | |
| THTARVLTTTTTTVA | 4646 | Q9HC84 | |
| SNSTITTSSTRVTKH | 1096 | Q14126 | |
| STSNLSSTSHERLTT | 8321 | Q8WXI7 | |
| RSTQTTRESQTSTLT | 201 | Q99102 | |
| TRESQTSTLTHRTTS | 206 | Q99102 | |
| STRTRTPVAHTNSAT | 1551 | Q6W4X9 | |
| SQSTTSRSTSLTTRV | 2266 | Q6W4X9 | |
| MASTSTTIRSHSSSR | 1 | P48668 | |
| TSSTTSSITRHTVDQ | 2286 | Q9NZR2 | |
| MASTSTTIRSHSSSR | 1 | P02538 | |
| SLSCSQSRSRSRSHT | 936 | Q9UKJ3 | |
| MASTSTTIRSHSSSR | 1 | P04259 | |
| HTTISSTTRTTERTP | 216 | Q02505 | |
| SSITTTETTSHNTRS | 2326 | Q02505 | |
| RRTTRITSQMTTQST | 2936 | Q02505 | |
| ASTTRAQTTRTSAIS | 21 | P22079 | |
| LGSHIRASSSSSSIR | 826 | Q14005 | |
| QSVRHTTRKSSTTLR | 386 | Q9BZL6 | |
| STLTSVSSHDSRLTA | 1511 | P16144 | |
| ESRSTAVTRTSSIHQ | 276 | Q8NDX5 | |
| GSFSTRIRSHSTIRT | 346 | D6RGH6 | |
| RSRLTATSTSQATDH | 106 | Q96JP2 | |
| RSTHRSTLTSHTSNL | 386 | Q9UHM6 | |
| TSSQSTFVAHSRVTR | 961 | Q9P2Q2 | |
| TSCLRHFSQTSRSTT | 1871 | Q13315 | |
| STFSSRRILTTSSAH | 61 | Q7L8L6 | |
| STLSSSSSSRERLHQ | 101 | O60307 | |
| RRTNTSSVTTTITQS | 256 | Q9P0J7 | |
| SLSDLTHRRNTSTSS | 251 | Q5T9C2 | |
| FHTTISSTTRTTERT | 216 | Q9H195 | |
| TTTTTTTTSNTTHRV | 761 | Q9HCJ0 | |
| LRESHSHTVTNRSST | 621 | O75925 | |
| SHTVTNRSSTDTASI | 626 | O75925 | |
| NLTRSSSSDSIHSVR | 931 | Q8WYL5 | |
| SERSTRLLTKTSHSQ | 101 | Q7L1S5 | |
| RARSHTVTTTASSFA | 6 | Q8IZV2 | |
| TVRLSTSSNSQRATH | 1196 | Q63HN8 | |
| SLSSRHTTLLTRSSC | 371 | P47901 | |
| SRTHSSVIATSKLSV | 541 | O60673 | |
| RTTSKEISVIQHTSS | 791 | Q5T1R4 | |
| SVSSSLRRHETTHSA | 291 | Q8TA94 | |
| TRSRASSLSITVEHA | 836 | Q6ZS17 | |
| SAVTTTAHLATTRNT | 246 | Q9NSU2 | |
| HTASTAPSTRRQETS | 1636 | Q702N8 | |
| TLSRSLSRESSLSHT | 1301 | P15822 | |
| LQRASTTTHRTATTT | 131 | Q96H15 | |
| TTTHRTATTTTRRTT | 136 | Q96H15 | |
| VSSTAVRTQHTTTRP | 731 | P01130 | |
| RSEESRTSHSSTTHT | 1936 | Q9UKN1 | |
| VSAQLTSTRHRRNTS | 171 | Q8NEV4 |